BEAM (STOCKS)
Beam Therapeutics Inc. Common Stock
$26.510000
-0.200000 (-0.75%)
Prev close: $26.710000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John Evans
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,821.63M
- Employees
- 510
- P/E (TTM)
- -31.05
- P/B (TTM)
- 2.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
11
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.18 | $-1.13 | -0.0515 | -4.56% |
|
Mar 2026 (Q1)
|
$-0.91 | $-1.12 | +0.2075 | +18.57% |
|
Dec 2025 (Q4)
|
$-0.10 | $-1.01 | +0.9085 | +89.82% |
|
Sep 2025 (Q3)
|
$-1.10 | $-1.06 | -0.0395 | -3.72% |
Financial Statements
| Revenues | $156.04M |
| Benefits Costs and Expenses | $241.46M |
| Costs And Expenses | $241.46M |
| Nonoperating Income/Loss | $292.60M |
| Operating Expenses | $534.06M |
| Depreciation and Amortization | $22.24M |
| Research and Development | $408.66M |
| Other Operating Expenses | $103.15M |
| Operating Income/Loss | -$378.02M |
| Income/Loss From Continuing Operations After Tax | -$85.43M |
| Income/Loss From Continuing Operations Before Tax | $37.74M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$85.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$85.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$85.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.68 |
| Diluted Earnings Per Share | -$0.68 |
| Basic Average Shares | 207,706,425 |
| Diluted Average Shares | 207,706,425 |
| Assets | $1.39B |
| Current Assets | $1.18B |
| Cash | $1.20B |
| Noncurrent Assets | $207.76M |
| Fixed Assets | $97.61M |
| Other Non-current Assets | $110.15M |
| Liabilities | $318.91M |
| Current Liabilities | $80.88M |
| Accounts Payable | $13.10M |
| Wages | $14.07M |
| Other Current Liabilities | $53.71M |
| Noncurrent Liabilities | $238.03M |
| Long-term Debt | $100.26M |
| Other Non-current Liabilities | $137.77M |
| Equity | $1.07B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.07B |
| Liabilities And Equity | $1.39B |
| Net Cash Flow From Operating Activities | -$359.38M |
| Net Cash Flow From Operating Activities, Continuing | -$359.38M |
| Net Cash Flow From Investing Activities | $189.46M |
| Net Cash Flow From Investing Activities, Continuing | $189.46M |
| Net Cash Flow From Financing Activities | $107.69M |
| Net Cash Flow From Financing Activities, Continuing | $107.69M |
| Net Cash Flow | -$62.23M |
| Net Cash Flow, Continuing | -$62.23M |
| Comprehensive Income/Loss | -$85.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$87.63M |
| Other Comprehensive Income/Loss | -$235.42M |
| Other Comprehensive Income/Loss Attributable To Parent | -$2.20M |